We are delighted to have had Patient and Public Involvement (PPI) from CanTest’s inception. Patients’ views are at the core of the whole programme and will be represented throughout the research lifecyle, development of the International School in Cancer Detection Research, on funding applications, and on the steering and stakeholder groups.
The PPI lead for CanTest is Margaret Johnson, who also provided PPI for the NIHR-funded DISCOVERY programme, a collaboration between five UK universities. Many findings from the DISCOVERY programme progressed our understanding about cancer detection and diagnosis in primary care and contributed to the development of the CanTest Collaborative.
More information coming soon about the role of PPI in CanTest and how you can get involved in our research.